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!13 (CK13) and 
cytokeratin 14 (CK14) immunohistochemistry. Ultrastructural analysis confirmed the 
presence of desmosomes and hemidesmosomes in the epithelial layer, a continuous 
basement membrane and newly synthesized collagen in the connective tissue layer. 
Quantitative PCR (qPCR) assessment of osteogenesisrelated gene expression showed a 
higher expression of genes encoded Collagen I (COL1) and Osteonectin (ON) as well as 
Osteocalcin (OC), Osteopontin (OPN), and Alkaline phosphatase (ALP). ELISA 
quantification of collagen I, ON, and OC confirmed a pattern of secretion which paralleled 
the model’s gene expression profile. We demonstrate here that replicating the anatomical 
setting between oral mucosa and the underlying alveolar bone is feasible and the developed 
model showed characteristics similar to those of normal tissue counterparts. This trilayered 
model therefore offers great scope as an advanced, and anatomicallyrepresentative tissue
engineered alternative to animal models. 
 
!Bone engineering, oral mucosa engineering, alveolar bone mucosal model, 
composite tissue engineering. 
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 Despite this 
challenge, 3D 	 	 screening systems, based on human cells and tissues, have already 
attracted significant attention, as they offer more robust and predictive experimental data 
compared to 2D or animal models.
(2) 
Limitations of 2D models include the loss of a natural 
3D environment, which is in turn reflected in cell behaviour,
(3)
 and additionally the absence 
of a 3D environment excludes important factors such as hypoxic gradients and drug 
penetration.  Furthermore, animal studies may misleading due to interspecies molecular and 
physiological differences.
(4)
 Therefore, the shortterm need for anatomicallyrepresentative 
3D models of the orofacial region is assured. Future development of these models beyond 
experimental analysis furthermore offers potential to achieve the longerterm goal of 
establishing tissue engineered grafting materials capable of improving and simplifying the 
reconstruction of surgical defects in the orofacial region. 
Over the last few decades, there has been a substantial amount of innovation and progress in 
the engineering of various tissues found in the orofacial region, such as cartilage, bone, 
mucosa, and periodontium.
(5)
 This has encouraged researchers to develop more intricately
structured hybrid tissues that differ in the characteristics of their constituent parts, yet 
comprise a single functional unit. To date, only a few examples of composite tissues have 
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15/LO/0116).  The study included simultaneous tissue engineering of oral mucosal model 
(OMM) and bone model (BM), then combining both to form a composite alveolar bone 
mucosal model (ABMM) (Figure1). All materials were purchased from Sigma Aldrich, UK 
unless otherwise stated.
%#%#∃



∋
Normal human oral keratinocytes (NHOKs) and normal human oral fibroblasts (NHOFs) 
were isolated from gingival biopsies as previously described with some modifications.
(10)
 
Briefly, the gingival tissues were collected and kept for 45 hours at 4ºC in transport medium 
consisting of serum free Dulbecco’s Modified Eagles Medium (DMEM)GlutaMAX™ 
(Gibco, USA) supplemented with 100 IU:100 mg ml
1
 penicillinstreptomycin (P/S) and 625 
ng ml
1 
fungizone. NHOKs were then enzymatically isolated from the biopsies by incubating 
the tissue in 0.25% trypsinEDTA for 1416 hours at 4ºC. The epithelial layer was then 
scraped, cut into small pieces, and plated in 25 cm
2
 tissue culture flask at a density of 1.5×10
6
 
with an equal number of i3T3 feeder layer fibroblasts. The keratinocytes were then cultured 
in a humidified atmosphere of 5 % CO2 /95 % air at 37 °C in Green’s medium.
(11)
  
NHOFs were isolated from the connective tissue layer by incubating in 0.05% (w/v) 
collagenase type I (Gibco, USA) in DMEMGlutaMAX™ containing 10% Fetal bovine 
serum (FBS at 37 °C for 4 hours. The digested tissue was then centrifuged at 200 g for 5 
minutes, and the resultant pellet resuspended in complete DMEM (CDMEM; DMEM
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Φ	)Η
Ι
#),,	
<!10% FBS, 625 ng/mL fungizone, and 100 IU:100 mg ml
1
 
P/S).  
Both NHOKs and NHOFs were fed three times a week until confluency and then used at 
passage 2. 
%#(#∃



∋


 
Primary human alveolar osteoblasts (HAOBs) were isolated from bone chips collected in a 
sterile bone trap during preparation of dental implant sites.
(12, 13)
 After collection in transport 
medium, the osseous tissues were extensively rinsed in phosphate buffered saline (PBS) and 
vortexed to remove blood components. Bone fragments were cultured as explants in 75 cm
2
 
flask in CDMEM supplemented with 50 µg/ml Lascorbic acid 2phosphate (LAA) at 37°C 
in a humidified atmosphere of 95% air, 5% CO2. The culture was left undisturbed for 7 days, 
after which the medium was replaced 23 times/week until the culture attained confluency, 
whereby cells were detached by trypsin/EDTA (0.25%), sub cultured, and used in the 3
nd
 
passage.  
%#)#


∗+,
Collagenbased OMM was constructed according to the technique described by Dongari
Bagtzoglou and Kashleva.
(14)
 A solution of 10 × DMEM 13.8 mg ml
1
, FBS 8.5% (v/v), L
glutamine 2 mM, reconstitution buffer (22 mg ml
−1
 sodium bicarbonate and 20 mM HEPES), 
and 5 mg ml
1 
rattail type I collagen (R & D system) was prepared on ice and neutralized by 
1M sodium hydroxide to pH=7.4.  
Finally, a cell suspension of NHOFs in CDMEM at a concentration of 2×10
5
 cells per model 
was added to the solution. The resultant fibroblastcontaining collagen was transferred into 
tissue culture inserts (0.4 µm pore size, 30 mm diameter, Millipore) and incubated at 37°C 
for 2 hours until solidified. 1.5 ml CDMEM was then added inside and outside the insert. 
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 6 # 1×10
6
 NHOK cells (per model) suspended in 50 µl Green’s medium were 
seeded on the gel surface and allowed to adhere for 3 hours. 2 ml Green’s medium was then 
gently added into the insert and incubated at 37 °C, 5% CO2 for 4 days. When epithelial cells 
reached confluency, the culture was raised to air/liquid interface and fed every other day for 
10 days. 
%#−#

∗, 
10 sterile ceramic discs (2mm × 10mm) of Hydroxyapatite/Tricalcium phosphate (HA/TCP) 
(60%/40%) (Ceramisys LTD, UK) with total porosity of 78.9 % were used as a scaffold. The 
discs were placed in 24 well plates and prewetted with CDMEM 24 hours before cell 
seeding.  2×10
6
 HOBs cells suspended in 15 µl CDMEM /LAA were then added dropwise to 
each scaffold. The cells were allowed to adhere for 2 hours, and then BMs completely 
covered with 2 ml CDMEM /LAA and incubated overnight. After 24 hours, BMs were 
suspended in a spinner bioreactor (Branstead Stem, UK) and spun at a rate of 30 rpm. The 
medium was changed every 2 days for 17 days.   
%#.#/
∗/, 
The assessment of cell viability within BMs and OMMs was performed using the PB assay 
(Invitrogen, USA) at day 17 before the combination of the two constructs. BMs and OMMs 
were separately placed in a 12 well tissue culture plate, washed with PBS, and then a 
mixture of 900 µl of CDMEM and 100 µl of PB reagent was added to each well. Three 
acellular discs and collagen gel were included as negative controls for BMs and OMMs, 
respectively. After 3 hours incubation at 37°C, the fluorescence values (excitation/emission: 
560/590 nm) of 200 Θl aliquot were measured in triplicates using spectrophotometric plate 
reader (Infinite® M200, TECAN, USA). For calculation, the average fluorescence values of 
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17, BM and OMM models were 
combined using a biocompatible fibrinbased adhesive sealant (ARTISS, Baxter, UK). In 
brief, BMs were retrieved and placed on a sterile culture plate containing 10 ml CDMEM. 
The fibrin adhesive was prepared in a prefilled syringe according to manufacturer’s 
instructions, and a thin layer of the mixed fibrinogenthrombin sealer applied to the non
epithelial side of an OMM. The OMM was then immediately attached to the surface of a BM 
and held in the desired position with gentle compression for a minimum of 60 seconds to 
ensure the adhesive material had completely set, and that both models were firmly adhered to 
each other. The ABMMs were then further cultured for 5 days, after which the analyses were 
performed. 
%#1#

2

 
ABMMs were fixed in 4% paraformaldehyde (PFA) for 24 hours and embedded in 2
hydroxyethyl methacrylate resin (Technovit 7100, Heraeus Kulzer) according to 
manufacturer’s instructions. Briefly, samples were dehydrated in graded ethanol series 75%, 
95%, 100% for at least 2 hours, then preinfiltrated with equal parts of basic solution and 
100% ethanol overnight on a rotating mixer. Infiltration was performed with infiltration 
medium consisting of 100 ml basic solution and 1 g Hardener1. Finally, samples were 
polymerized in suitable molds with premixed 15 ml infiltration medium and 1 ml Harderner
2. Polymerisation was completed over the period of 2 hours at room temperature. 
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For routine haematoxylin and eosin (H&E) staining (Leica Microsystems), the ground block 
was first sectioned into 100150 µm thickness with a cutting machine (IsoMet
®
 1000 
precision saw, Buehler UK Ltd, UK). The section was then adhered to a glass slide using 
cyanoacrylate adhesive (Loctite
®
 glass bond UV curing, UK). The thickness was then further 
reduced to 3035 µm by grinding the sections with silicon carbide papers of P800 and P1200 
roughness in a grinderpolisher machine (Buehler ™ Metaserv, UK). 
%#3#

4 ∃

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OMMs were processed for histological, IF, and TEM examination at the end of culture 
period. Frozen sections were prepared as previously described.
(15)
 OMM were fixed with 4% 
PFA for 24 hours, followed by an overnight incubation in 18% sucrose in PBS. The samples 
were frozen in OCT Compound (Thermofisher) and sectioned to 14 µm, and sections were 
then either stained with H&E for examination under inverted microscope (Olympus, Japan), 
or were subjected to IF staining. 
For IF staining, the sections were washed with PBS for 5 minutes, permeabilized with 0.2 % 
Triton x100 for 5 minutes, and then blocked with 1% bovine serum albumin (BSA) in 0.1 % 
PBSTween for 1 hour. The sections were then incubated overnight at 4 ºC with conjugated 
antiCytokeratin 13 (Abcam, UK, ab198584) and antiCytokeratin 14 (Abcam, UK, 
ab192055) antibodies at a working dilution of 1:100. After washing, slides were mounted 
using DAPIcontaining mounting medium (Thermofisher, UK) and viewed using IF 
microscopy (Zeiss Ltd, Germany). Normal oral mucosa (NOM) was used as a positive 
control, while negative control was OMM stained with IgG isotype (1:100) (ebioscience, 
UK), followed by gout anti rabbit secondary antibodies (1:200) (Abcam, UK, ab150083). 
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For TEM analysis, 4mm sections of OMM were fixed in 3% glutaraldehyde in 0.1 M sodium 
cacodylate buffer for 2 hours at 4°C, and post fixed in 1% osmium tetroxide for 2 hours. 
Tissue was dehydrated with 70%, 95%, and 100% ethanol and then embedded in resin. 
Samples were left for 48 hours in the oven at 60 ºC, and thereafter examined using a 
transmission electron microscope (FEI tecnai 12 Biotwin, 120Kv TEM). 
%#∀6# 7∋

∗8/9,2

For gene expression analysis, ABMMs were snap frozen, grinded, and digested with lysis 
buffer. RNA was isolated using isolate II RNA Mini Kit (BioLine, UK) according to 
manufacturer’s instructions. 500 ng total RNA was reverse transcribed using a HighCapacity 
RNA to Complementary DNA (cDNA) kit (Life Technologies, UK). 
0.5 µl cDNA was amplified using 5 µl TaqMan gene expression master mix, 3.5 µl nuclease 
free water and 0.5 µl TaqMan gene probes (Applied Biosystems). Genes encoding the 
following markers were then interrogated; ALP, Osteopontin (OP), Osteonectin (ON), 
Osteocalcin (OC), Collagen I (COL1), Ki 67, Cytokeratin 10 (CK10), and Cytokeratin 13 
(CK13).  B2Microglobulin was used as a reference control gene (All Applied biosystem, 
UK).  
Cycling conditions were holding at 95°C for 10 minutes, then 95°C for 10 seconds, followed 
by 60 °C for 45 seconds and the cycle was repeated 40 times (QIAGEN, Germany). The 
threshold cycle (Ct) was normalized against the reference gene (ς Ct) and the expression 
relative to it was calculated.
%#∀∀# 	:

∗;∃&,
Commercially available ELISA kits for COL1, ON (R&D systems, UK), and OC (Abcam, 
UK) were used according to manufacturer’s instructions in order to quantify these proteins in 
ABMM after 24 hours incubation in serum free tissue culture conditioned medium. The 
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solutions were read at absorbance 450 nm using a microplate reader (Infinite® M200, 
TECAN, USA).  
%#∀%# &  
All data were presented in terms of mean ± SD of three independent experiments performed 
in triplicate. Oneway ANOVA complemented by Tukey's multiple comparisons test was 
performed using GraphPad Prism v7.0 (GraphPad Software, La Jolla, CA), and differences 
were considered significant when p < 0.05. 
(# 9

(#∀#<
Cell viability testing using the PB assay revealed that HAOBs within the bone model as well 
as NHOFs and NHOKs in the OMM remained vital throughout the experiment (Figure 2). 
(#%#



Histological observation revealed that the ABMM had a structure consisting of epithelial, 
connective tissue and bony layers which were comparable to the histological architecture of 
the soft and hard tissues of the oral cavity (Figure 3A). The model’s surface displayed a 
continuous stratified epithelial layer, and a connective tissue layer densely populated with 
viable fibroblasts (Figure 3B). The hardsoft tissue interface showed a thin band of cell
infiltrated sealant adhering both layers (Figure 3C). Viable cells evenly populated the 
scaffold porosities with a secreted matrix partially or completely filling the pores of the 
scaffold (Figure 3D). 
(#(#+ 
Histologically, the OMM showed a proliferating basal layer and welldifferentiated stratified 
squamous oral epithelium of 1214 NHOKs thickness, which mimicked that of NOM (Figure 
4). The epithelium consisted of four distinct layers that included equivalents to basal, spinous, 
intermediate, and superficial cells, respectively. The uppermost aspect of the superficial layer 
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had cells of a flattened appearance, while cells in the basal layer remained rounded. Glycogen 
granules were occasionally observed in the intermediate layer. NHOFs were found dispersed 
homogeneously in the connective tissue. 
Figure 5 shows the keratin expression of NOM and OMM, as assessed by immunofluorescent 
staining for CK13 and CK14. The suprabasal cells of the OMM strongly expressed CK13, 
consistent with the staining of intermediate and superficial cells in parakeratinized stratified 
epithelium.
(16)
 CK14 was expressed throughout the entire epithelium. 
 Ultrastructural analysis of the OMM demonstrated the presence of numerous desmosomes 
between adjacent epithelial cells (Figure 6A). A continuous and intact basement membrane 
was formed, anchoring the epithelium firmly to the connective tissue by means of 
hemidesmosomal attachments (Figure 6B). In the supepithelial layer, a high amount of 
newly synthesized collagen was observed (Figure 6C). 
(#)#8/9
Figure (7) summarises gene expression for the composite model, including both HAOB and 
NHOK cell components. Of all genes evaluated, COL1 demonstrated the highest level of 
expression. Bonespecific genes such as ALP, OC, ON, and OP were detected, with ON 
expressed in high quantities. Genes encoding CK10 and CK13 were expressed, and were not 
significantly different. 
(#−#;∃&
ELISA results for COL1, ON, and OC were consistent with the qPCR findings. COL1 
demonstrated a significantly increased protein concentration in comparison to ON and OC. 
ON, in turn, was higher than OC (Figure 8).  
)# =
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There is an increasingly recognized need to engineer tissue equivalents for both clinical 
and experimental applications. In this study, we have developed and characterized an 		 
3D human alveolar osteomucosal construct that replicates the natural anatomical relationship 
of oral mucosal tissue and the underlying bone. 
In 3D culture, cell viability is influenced by several factors including the scaffold and culture 
environment. Calcium phosphate and collagen constitute the main elements of the 
extracellular matrix of bone and oral mucosa, respectively.
(17)
 Therefore, due to their 
biocompatibility, they have been widely used in tissue engineering  as scaffolds to support 
cells growth without compromising their vitality.
(18) 
The culture environment, on the other 
hand, that promotes mass transfer and nutrient delivery is another important factor to 
maintain cell vitality. In our study, growing OMM in a static culture raised no problem due to 
the hydrophilic, high watercontaining networks of collagen hydrogel that enhance 
permeability for oxygen, nutrients and watersoluble metabolites.
(19)
 Ceramicbased bone 
model, by contrast, required a dynamic flow to improve nutrient and waste diffusion because 
the static culture is only sufficient to nourish the thin superficial layer, approximately 100
200µm, contacting the medium.
(20)
 As the cells increase in number, so does their metabolic 
demand and the buildup of waste products. Consequently, the deeper cells in the tissue 
interior can be deprived of oxygen and nutrients source in longterm static culture conditions. 
For this reason, the total culture time of the composite tissue after combining the hard and 
soft tissue constructs was limited to an additional 5 days at the static air/liquid interface in 
this study. 
We have shown that the histological structure and expression of key markers of epithelial 
differentiation in OMM were comparable to those of its normal tissue counterpart. OMM 
displayed the characteristics of a parakeratinized epithelium, which suggests that the 
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keratinocytes used in this model retain the parakeratinized status of the original oral mucosa 
from which they were derived.
(21)
  
The control of keratinocyte in proliferation and differentiation is multifactorial. Several 
studies have confirmed the role of fibroblasts in epithelial development through the 
stimulation of keratinocyte proliferation, migration, and keratin expression.
(22, 23)
 Fibroblasts 
establish such growthpromoting roles through paracrine cross talk between NHOFs and 
NHOKs via cytokines such as heparinbinding EGFlike growth factor (HBEGF), 
Interleukin 1 alpha (IL1α) and Transforming growth factor beta 1 (TGFβ1).
(24)
 This 
function requires an optimal fibroblast density, as the presence of either excessive or 
inadequate numbers of fibroblast will adversely affect epithelium morphogenesis, leading to 
differentiation markers being inappropriately expressed.
(25)
 In our models, optimal fibroblast 
seeding density in order to support an anatomically representative epithelial layer was found 
to be 2 × 10
5
 cells per model. Keratinocyte senescence may also impact on the capacity to 
achieve anatomically representative epithelia in tissue culture models.  Due to sustained 
telomerase expression within primary cells, sequential sub culturing may restrict the capacity 
of keratinocytes to divide once seeded into a 3D model, and therefore it is recommended that 
the use of keratinocytes in tissue substitute constructs is limited to passage 3 or less.
(26)
 
The proper functionality of keratinocytes is important not only for epithelial layer formation, 
but also for epithelialconnective tissue attachment and cellcell adhesion, which are essential 
for achieving an accurate, functional mucosal substitute. Our data, consistent with data from 
other studies, has confirmed that cells within the 3D models actively synthesised the 
ultrastructural components including desmosomes, hemidesmosomes, and basement 
membrane required for this structural stability.
(27, 28)
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Although collagen I is a nonspecific marker of osteogenesis, relatively high levels were 
expressed in our model compared to other osteogenic genes; this may be due to a number of 
reasons. Firstly, this marker constitutes the most abundant component of bone extracellular 
matrix (90% of the organic component) and becomes upregulated during bone formation.
(29)
 
Secondly,  ascorbic acid was added as a component of the culture medium in order to 
maintain the osteoblastic phenotype of bonederived cells; ascorbic acid is known to 
stimulate of cell growth and collagen synthesis in osteoblasts.
(30)
 The hydroxylation of 
proline residues of procollagen is increased to approximately 40% by ascorbate, which is 
known to stabilize the collagen triple helix.
(31)
 Thirdly, although collagen I is the main 
organic component secreted by osteoblasts, it is also produced in abundance by fibroblasts 
(32, 
33)
, and therefore the fibroblastic component of the model may have contributed to the 
collagen levels observed. 
We undertook analysis of further osteoblastic markers, including Osteocalcin, Osteopontin, 
Osteonectin and ALP. ALP, like Collagen I, is expressed in tissues other than bone and 
therefore its expression cannot be considered specific, although it is synthesised by 
osteoblasts and has been used to assess osteoblast phenotype and matrix mineralization.
(34)
 
Conversely, Osteocalcin, Osteopontin, and Osteonectin are major noncollagenous, bone
specific proteins that play profound roles in bone formation.
(29)
 Osteonectin, in particular, is 
localized to mineralized bone trabeculae and is present at higher concentrations within 
extracellular matrix than in osteocytes. It selectively binds to collagen I and the resultant 
osteonectincollagen complexes initiate mineral phase deposition by binding synthetic apatite 
crystals and free calcium ions.
(35)
 Interestingly, Osteonectin can be demonstrated in active 
osteoblasts and osteoprogenitor cells as well as in young osteocytes, but not in aged, 
quiescent osteocytes; the protein is therefore  a reliable marker of functional osteoblasts.
(36)
 
The simultaneous expression of Osteonectin and its encoding gene, SPARC, strongly 
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suggests that HOBs maintained their phenotypic characteristics in spite of a protracted culture 
period of 2 months. 
The expression of all osteoblastassociated molecules varies over the different stages of 
bone development, and therefore the expression profiles observed in our models, which 
were cultured over a relatively short period compared to that of normal human bone 
turnover may vary somewhat to that observed 		. For example, ALP increases in the 
initial stages of bone formation, yet decreases as mineralization progresses, whereas 
osteopontin is first detected in young bone, whilst Osteocalcin appears towards the end of 
the mineralization process.
(37) 
 
 
−#


This study demonstrates that tissue engineered trilayered reconstructs based on primary 
human alveolar osteoblasts cultured in porous hydroxyapatite/tricalcium phosphate scaffolds 
adhered to collagenembedded gingival fibroblasts overlain with primary gingival 
keratinocytes cultured at the air/liquid interface, were able to mimic the native alveolar bone 
and overlaying fullthickness mucosal structures. The engineered combined hard and soft 
tissue provides scope to act as a valuable alternative to 2D and animal models for various 	
	 and potential 	 	 applications. Further experiments are underway to assess the 
suitability of this 3D model for 		 evaluation of bone invasion of oral cancer as well as 
development of 		 tissue engineered models of osseointegrated dental implants using the 
3D composite bone mucosal system. 
 
:
 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Figure legends: 
Figure 1. Schematic illustration of the preparation of OMM, BM, and ABMM. The 
procedure involved 3 main steps. First; HAOBs, NHOFs, and NHOKs were isolated from 
oral tissues and cultivated in monolayer culture. Second; BMs were prepared by seeding 
HAOBs in HA/TCP scaffold and cultured in spinner bioreactor while OMMs were prepared 
from fibroblast-populated collagen gel and air liquid interface culture oral keratinocytes. 
Third; Combination of BM and OMM using adhesive fibrin to form ABMM.  
Figure 2. Vitality assessment of OMMs and BMs. The figure shows the activity of HAOBs 
within HA/TCP scaffold as well as NHOFs and NHOKs in OMMs after 17 days of culture. 
Figure 3. H&E-stained histological sections of ABMM showing (A) full-thickness multi-
layered bone and mucosa; and magnified images of (B) oral mucosa part; (C) bone-mucosal 
interface; and (D) bony part showing the pores of the scaffold filled with osteoblasts and 
extracellular matrix (Original magnification A × 4; B, C, and D×10). 
Figure 4. H&E-stained histological sections of (A) NOM; and (B) OMM showing a well-
differentiated stratified squamous epithelial layer with viable fibroblasts scattered in the 
connective tissue layer (Original magnification ×20). 
Figure 5. Immunofluorescent staining of the oral mucosa showing (A and D) both 
epithelial markers CK13 and CK14 were well detected in the NOM; (B and E) strong 
expression of CK13 and CK14 in the OMM; and (C, F) negative control (Original 
magnification ×20; the lower left boxes are DAPI stain). 
Figure 6. Ultrastructural analysis of the OMM by transmission electron microscopy 
showing (A) numerous desmosomes (D) between adjacent epithelial cells; (B) basement 
membrane (BM) formed all along the interface between the epithelial cell (EC) and 
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connective tissue (CT) with the presence of hemidesmosomes (HD); and (C) newly 
synthesized collagen I fibrils in the connective tissue (Original magnification × 50000). 
Figure 7. The gene expression of HAOBs and NHOKs in the ABMM as evaluated 
with PCR analysis. The osteogenic markers; OC, ALP, OP, ON, and COL1, in addition to 
the epithelial markers; CK10, CK13 were detected. Statistical significance was determined 
as p<0.05 from control (**** P<0.0001). 
Figure 8. Protein expression of Collagen I, Osteonectin, and Osteocalcin in ABMM analyzed 
by ELISA. Statistical significance was determined as p<0.05 (**** P<0.0001). 
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